These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27751594)

  • 1. Polymer-Based Materials in Cancer Treatment: From Therapeutic Carrier and Ultrasound Contrast Agent to Theranostic Applications.
    Methachan B; Thanapprapasr K
    Ultrasound Med Biol; 2017 Jan; 43(1):69-82. PubMed ID: 27751594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-sized Ultrasound Contrast Agents for Cancer Therapy and Theranostics.
    Li H; Gan S; Feng ST; Zhou G; Dong Z; Zheng R; Li ZP
    Curr Pharm Des; 2017; 23(35):5403-5412. PubMed ID: 28699518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.
    Min HS; Son S; You DG; Lee TW; Lee J; Lee S; Yhee JY; Lee J; Han MH; Park JH; Kim SH; Choi K; Park K; Kim K; Kwon IC
    Biomaterials; 2016 Nov; 108():57-70. PubMed ID: 27619240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-lipospheres as acoustically active ultrasound contrast agents: evolving tumor imaging and therapy technique.
    Andrews LE; Chan MH; Liu RS
    Nanotechnology; 2019 May; 30(18):182001. PubMed ID: 30645984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctionalized Microscale Ultrasound Contrast Agents for Precise Theranostics of Malignant Tumors.
    Fu JW; Lin YS; Gan SL; Li YR; Wang Y; Feng ST; Li H; Zhou GF
    Contrast Media Mol Imaging; 2019; 2019():3145647. PubMed ID: 31360144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
    Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
    Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
    Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
    Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-Based Materials and their Applications in Image-Guided Cancer Therapy.
    Sun Y; Ran H; Liu F
    Curr Med Chem; 2022 Mar; 29(8):1352-1368. PubMed ID: 34137360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
    Zhou LQ; Li P; Cui XW; Dietrich CF
    Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
    Tay LM; Xu C
    Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Theranostic Microbubbles Using Microfluidics for Ultrasound Imaging and Therapy: A Review.
    Pulsipher KW; Hammer DA; Lee D; Sehgal CM
    Ultrasound Med Biol; 2018 Dec; 44(12):2441-2460. PubMed ID: 30241729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y; Han X; Jing X; Chen Y
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic mediators for ultrasound theranostics.
    Józefczak A; Kaczmarek K; Bielas R
    Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy.
    van Rooij T; Daeichin V; Skachkov I; de Jong N; Kooiman K
    Int J Hyperthermia; 2015 Mar; 31(2):90-106. PubMed ID: 25707815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors.
    Domingues C; Alvarez-Lorenzo C; Concheiro A; Veiga F; Figueiras A
    Mol Pharm; 2019 Dec; 16(12):4757-4774. PubMed ID: 31633939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential.
    Jablonowski LJ; Alfego D; Andorko JI; Eisenbrey JR; Teraphongphom N; Wheatley MA
    Biomaterials; 2016 Oct; 103():197-206. PubMed ID: 27388945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.